What the BPC-157 + TB500 + MGF Blend is
This product is one lyophilized vial holding three separately synthesized peptides at a stated total of 18.5 mg: 10 mg of BPC-157, 7.5 mg of TB500 and 1 mg of MGF. BPC-157 is the fifteen-residue sequence GEPPPGKPADDAGLV. TB500 is a synthetic fragment of the actin-binding region of thymosin beta-4. MGF, short for mechano growth factor, is a peptide based on the E-domain of an IGF-1 splice variant, and at 1 mg it makes up a little over 5% of the stated total.
Differing in length, charge and hydrophobicity, the three components make the blend a different analytical object from any one of them, and the uneven 10 : 7.5 : 1 split is part of its definition.
BPC-157 + TB500 + MGF Blend 18.5mg specification
| Catalog name | BPC-157 + TB500 + MGF Blend |
|---|---|
| Composition | BPC-157 10 mg; TB500 (Ac-LKKTETQ, thymosin beta-4 fragment 17–23, approx. 889.0 g/mol) 7.5 mg; MGF 1 mg |
| BPC-157 component | GEPPPGKPADDAGLV, C62H98N16O22, approx. 1419.5 g/mol, CAS 137525-51-0 |
| Total amount per vial | 18.5 mg |
| Form | Lyophilized powder, sealed vial |
| HPLC purity | ≥98% |
| Shelf life | 36 months in the sealed vial |
How the BPC-157 + TB500 + MGF Blend is analyzed
A single-peptide chromatogram has one intended main peak; this one has three, so the method has to resolve each component from the other two and from each component’s own impurities. At 280 nm only a component carrying tryptophan or tyrosine absorbs meaningfully, so the low-UV trace near 214 nm, where every peptide bond is seen, is the sensible basis for reading a mixture. BPC-157 brings proline-driven band broadening, and the short, polar TB500 fragment tends to elute early.
Identity in a mixture needs one mass confirmation per component rather than one per vial, and the 1 mg MGF signal is the easiest to overlook beside the two larger ones. This three-way mixture has one independent reverse-phase HPLC record, posted here; as the vials are unnumbered, crimp and cap color is the means of tying a given vial to it.
Research contexts for the BPC-157 + TB500 + MGF Blend
- HPLC method development for resolving three peptides of unequal proportion in one run
- Per-component LC-MS identity confirmation, including detection of a minor component
- Net peptide content work where each component carries its own counter-ion load
- Side-by-side analytical comparison with the single-compound BPC-157 and TB-500 vials
The blend is a laboratory reference mixture for in-vitro and analytical research and is excluded from any use in humans or animals.
BPC-157 + TB500 + MGF Blend questions
Do the peak areas reproduce the 10 : 7.5 : 1 mass ratio?
Not directly. Each peptide absorbs UV differently per milligram and carries its own counter-ion and water content, so raw area percentages and stated component masses answer different questions.
How many identity confirmations does a three-peptide vial need?
Three: one observed mass for each intended component. A single confirmed mass establishes only the component it belongs to.
Can this blend stand in for the separate BPC-157 and TB-500 products?
No. It is a distinct product with its own composition and published analysis, and records should name it in full rather than by its first component.
Buying the BPC-157 + TB500 + MGF Blend 18.5mg in the USA
The three-component 18.5mg vial ships domestically from the US with tracking attached, and a cart above $100 earns free shipping. Labs using this mixture for recurring separation or LC-MS work can ask for bulk terms. Access to the blend is reserved for research institutions, licensed researchers, universities and laboratory R&D purchasers. Blend analysis is covered in depth in our reference on separating, confirming and reporting a three-component peptide vial.
This 18.5mg blend is an in-vitro laboratory mixture, barred from human and veterinary use, with no preparation or dosing guidance offered.
6 reviews for BPC-157 + TB500 + MGF Blend 18.5mg